Vaccination against multiple HPV types

Mathematical Biosciences

Volumn 197, Issue 1, 2005, Pages 88-117

  Elbasha, Elamin H ^a   Galvani, Alison P ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Coevolutionary interactions; HPV disease; HPV types; Local stability; Mathematical model; Vaccine

Indexed keywords

DISEASES; MATHEMATICAL MODELS; TUMORS;

CERVICAL CANCER; LOCAL STABILITY;

VACCINES;

CANCER;

ARTICLE; EPIDEMIOLOGICAL DATA; HEALTH PROGRAM; MASS IMMUNIZATION; MATHEMATICAL MODEL; SEROTYPE; SIMULATION; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; WART VIRUS;

FEMALE; HUMANS; MATHEMATICS; MODELS, IMMUNOLOGICAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL VACCINES;

HUMAN PAPILLOMAVIRUS TYPES;

EID: 28844439739     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2005.05.004     Document Type: Article

References (56)

1. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol. 55 2002 244
2. D. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int. J. Cancer. 94 2001 153
3. R. Insinga, A. Glass, and B. Rush The healthcare costs of cervical human papillomavirus-related disease Am. J. Obstet. Gynecol. 191 2004 114
4. S. Chan, H. Delius, A. Halpern, and H. Bernard Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy J. Virol. 69 1995 3074
5. G. Ho, R. Bierman, L. Beardsley, C. Chang, and R. Burk Natural history of cervicovaginal papillomavirus infection in young women N. Engl. J. Med. 338 1998 423
6. R. Herrero, A. Hildesheim, C. Bratti, M. Sherman, and M. Hutchinson A population-based study of human papillomavirus infection and all grades of cervical neoplasia in rural Costa Rica J. Natl. Cancer. Inst. 92 2000 464
7. F. Bosch, M. Manos, N. Munoz, M. Sherman, and A. Jansen Prevalence of human papillomavirus in cervical cancer: a worldwide perspective J. Natl. Cancer. Inst. 87 1995 796
8. E.-M. DeVilliers Heterogeneity of the human papillomavirus group J. Virol. 63 1989 4898
9. L.A. Koutsky, K.A. Ault, C.M. Wheeler, D.R. Brown, and E. Barr A controlled trial of a human papillomavirus type 16 vaccine N. Engl. J. Med. 347 2002 1645
10. D. Brown, K. Fife, C. Wheeler, L. Koutsky, and L. Lupinacci Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine Vaccine 22 2004 2936
11. K. Fife, C. Wheeler, L. Koutsky, E. Barr, and D. Brown Dose-ranging studies of the safety and immunogenicity of human papillomavirus type 11 and type 16 virus-like particle candidate vaccine in young healthy women Vaccine 22 2004 2943
12. K.U. Jansen, and A.R. Shaw Human papillomavirus vaccines and prevention of cervical cancer Annu. Rev. Med. 55 2004 319
13. K. Thomas, J. Hughes, J. Kuypers, N. Kiviat, and S.-K. Lee Concurrent and sequential acquisition of different genital human papillomavirus types J. Infect. Dis. 182 2000 1097
14. K.-L. Liaw, A. Hildesheim, R. Burk, P. Gravitt, and S. Wacholder A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types J. Infect. Dis. 183 2001 8
15. M.-C. Rousseau, J. Pereira, J.C. Prado, L. Villa, T. Rohan, and E. Franco Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection J. Infect. Dis. 184 2001 1508
16. F. Unckell, R. Streeck, and M. Sapp Generation and neutralization of pseudovirions of human papillomavirus type 33 J. Virol. 71 1997 2934
17. L.J. White, M.J. Cox, and G.F. Medley Cross immunity and vaccination against multiple microparasite strains IMA J. Math. Appl. Med. Biol. 15 1998 211
18. R. Roden, H. Greenstone, and R. Kirnbauer In vitro generation and type specific neutralization of a human papillomavirus type 16 virion pseudotype J. Virol. 70 1996 5875
19. R. Roden, N. Hubbert, R. Kirnbauer, N. Christensen, D. Lowy, and J. Schiller Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition J. Virol. 70 1996 3298
20. J. Carter, L.A. Koutsky, and G. Wipf The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women J. Infect. Dis. 174 1996 927
21. R. Roden, W. Yutzy, R. Fallon, S. Inglis, D. Lowy, and J. Schiller Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes Virology 270 2000 254
22. G.Y.F. Ho, Y. Studentsov, C.B. Hall, R. Bierman, and L. Beardsley Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles J. Infect. Dis. 186 2002 737
23. R. Kirnbauer, N. Hubbert, C. Wheeler, T. Becker, D. Lowy, and J. Schiller A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 J. Natl. Cancer. Inst. 86 1994 494
24. T. Sasagawa, H. Yamazaki, Y. Dong, S. Satake, M. Tateno, and M. Inoue Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions Int. J. Cancer 75 1998 529
25. A. McLean Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework Proc. R. Soc. Lond. B 261 1995 389
26. M. Lipsitch Vaccination against colonizing bacteria with multiple serotypes Proc. Natl. Acad. Sci. 94 1997 6571
27. T.C. Porco, and S.M. Blower Designing HIV vaccination policies: subtypes and cross-immunity Interfaces 28 1998 167
28. M. Lipsitch Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae Emerg. Infect. Dis. 5 1999 336
29. T.C. Porco, and S.M. Blower HIV vaccines: the effect of the mode of action on the coexistence of HIV subtypes Math. Popul. Stud. 8 2000 205
30. M. Nowak, and R.M. May Superinfection and the evolution of parasite virulence Proc. R. Soc. Lond. B 255 1994 81
31. R.M. May, and M.A. Nowak Coinfection and the evolution of parasite virulence Proc. R. Soc. Lond. 261 1995 209
32. S. Gupta, N.M. Ferguson, and R.M. Anderson Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents Science 280 1998 912
33. J. Gog, and B. Grenfell Dynamics and selection of many-strain pathogens Proc. Natl. Acad. Sci. 94 2002 17209
34. S. Gupta, and A. Galvani The effects of host heterogeneity on pathogen population structure Philos. Trans. R. Soc. Lond. B 354 1999 711
35. L. Esteva, and C. Vargas Analysis of a Dengue disease transmission model Math. Biosci. 150 1998 131
36. N. Ferguson, R. Anderson, and S. Gupta The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens Proc. Natl. Acad. Sci. 96 1999 790
37. L. Esteva, and C. Vargas Coexistence of different serotypes of dengue virus J. Math. Biol. 46 2003 31
38. G. Garnett, and H. Waddell Public health paradoxes and the epidemiological impact of an HPV vaccine J. Clin. Virol. 19 2000 101
39. J. Hughes, G. Garnett, and L. Koutsky The theoretical population level impact of a prophylactic human papillomavirus vaccine Epidemiology 13 2002 631
40. J. Koopman Modeling infection transmission: the pursuit of complexities that matter Epidemiology 13 2002 622
41. R. Barnabas, and G. Garnett The Potential Impact of Vaccines Against Human Papillomavirus 2002 Imperial College of Science, Technology, and Medicine London, UK
42. H.W. Hethcote The mathematics of infectious diseases SIAM Rev. 42 2000 599
43. C. Casillo-Chavez, W. Huang, and J. Li Competitive exclusion and coexistence of multiple strains in an SIS STD model SIAM. J. Appl. Math. 59 1999 1790
44. C. Casillo-Chavez, W. Huang, and J. Li The effects of females' susceptibility on the coexistence of multiple pathogen strains of sexually transmitted diseases J. Math. Biol. 35 1997 503
45. R.M. May, S. Gupta, and A.R. Mclean Infectious disease dynamics: what characterizes a successful invader? Phil. Trans. R. Soc. Lond. B 356 2001 901
46. R.M. Anderson, and R.M. May Infectious Diseases of Humans: Dynamics and Control 1991 Oxford University Oxford
47. H. Richardson, G. Kelsall, P. Tellier, H. Voyer, and M. Abrahamowicz The natural history of type-specific human papillomavirus infections in female university students Cancer Epidemiol. Biomarkers. Prev. 12 2003 485
48. A. Giuliano, R. Harris, R. Sedjo, S. Baldwin, and D. Roe Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the young women's health study J. Infect. Dis. 186 2002 462
49. E. Franco, L. Villa, J. Sobrinho, J. Prado, and M.-C. Rousseau Epidemiology of acquisition and clearance of cervical Human Papillomavirus infection in women from a high-risk area for cervical cancer J. Infect. Dis. 180 1999 1415
50. M. Molano, A. Brule1, M. Plummer, E. Weiderpass, and H. Posso Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study Am. J. Epidemiol. 158 2003 486
51. V. Dalstein, D. Riethmuller, J.-L. Pretet, K. Carval, and J.-L. Sautiere Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study Int. J. Cancer. 106 2003 396
52. A. Frega, P. Stentella, C. Villani, D. Ruzza, and G. Marcomin Correlation between cervical intraepithelial neoplasia and human papillomavirus male infections: a longitudinal study Eur. J. Gynecol. Oncol. 20 1999 228
53. C. Nebesio, G. Mirowski, and T.-Y. Chuang Human papillomavirus: clinical significance and malignant potential Int. J. Dermatol. 40 2001 373
54. J.M. Hyman, J. Li, and E.A. Stanley The initialization and sensitivity of multigroup models for the transmission of HIV J. Theor. Biol. 208 2001 227
55. W.A.A. Tjalma, M. Arbyn, J. Paavonen, T.R. Van Waes, and J.J. Bogers Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer Int. J. Gynecol. Cancer 14 2004 751
56. D. Lowry, and I. Frazer Prophylactic human papillomavirus vaccines J. Natl. Cancer. Inst. Mongr. 31 2003 111